Verve Therapeutics, Inc.
Verve Therapeutics, Inc. (VERV) Insider Trading
Form 4 buy vs sell counts, ratio, and sentiment — switch this quarter or last 12 months; chart and transactions below.
SEC EDGAR · FMP · VERV · as of Jun 9, 2026
Activity summary
Buy transactions
1
P-Purchase only
Sell transactions
8
12 Months
Buy/Sell ratio
0.13
Buy/Sell (by trades)
Overall sentiment
Verve Therapeutics, Inc. insiders have been primarily selling shares over the past 12 Months. Selling activity is often driven by pre-scheduled Rule 10b5-1 plans rather than negative sentiment toward the company.
▸ Source: SEC EDGAR · Form 3 & 4 · via Financial Modeling Prep · Buy = P-Purchase only · Sell = S-Sale only
As of Jun 9, 2026
VERV insider buying and selling by quarter
VERV insider selling · VERV insider buying stocks · quarterly insider activity
Mobile shows last 4Q · Desktop shows full 8Q
▸ Source: SEC EDGAR · Form 3 & 4 · via Financial Modeling Prep · last 8 quarters
As of Jun 9, 2026
Active insiders
Most active in past 12 months · VERV ceo insider trading
Showing all insiders · Click a card to filter the transactions table below
▸ Aggregated from reportingName · top 5 by trade count (12M) · no extra API
Recent insider transactions
VERV executive sell shares · VERV board member insider trading · VERV insider trading SEC filing
Scroll horizontally to see all columns
| Date | Insider | Type | Shares | Value | Filing |
|---|---|---|---|---|---|
| Jul 25, 2025 | GV 2017 GP, L.L.C. 10 percent owner | Other | 1,800,000 | $18.90M⚡ | Form 4 |
| Jul 25, 2025 | Yeshwant Krishna Director | Other | 1,800,000 | $18.90M⚡ | Form 4 |
| Jul 25, 2025 | Dorval Allison CFO | Other | 13,280 | $139K | Form 4 |
| Jul 25, 2025 | Nickerson Joan Chief Administrative Officer | Other | 17,420 | $183K | Form 4 |
| Jul 25, 2025 | Kathiresan Sekar CEO · Director | Other | 240,997 | $2.53M⚡ | Form 4 |
| Jul 25, 2025 | Lister Troy Chief Scientific Officer | Other | 6,952 | $73K | Form 4 |
| Jul 25, 2025 | ADELMAN BURT A Director | Other | 428,326 | $4.50M⚡ | Form 4 |
| Jul 25, 2025 | Ashe Andrew D. See Remarks | Other | 348,828 | $3.66M⚡ | Form 4 |
| Jul 25, 2025 | Politi Jason Chief Technical Ops. Off. | Other | 16,405 | $172K | Form 4 |
| Apr 1, 2025 | Kathiresan Sekar CEO · Director | Option | 33,000 | — | Form 4 |
| Apr 2, 2025 | Kathiresan Sekar CEO · Director | Sale | 9,822 | $41K | Form 4 |
| Apr 1, 2025 | Nickerson Joan Chief Administrative Officer | Option | 9,315 | — | Form 4 |
| Apr 2, 2025 | Nickerson Joan Chief Administrative Officer | Sale | 2,777 | $12K | Form 4 |
| Apr 1, 2025 | Ashe Andrew D. See Remarks | Option | 9,000 | — | Form 4 |
| Apr 2, 2025 | Ashe Andrew D. See Remarks | Sale | 2,681 | $11K | Form 4 |
| Apr 1, 2025 | Politi Jason Chief Technical Ops. Off. | Option | 8,815 | — | Form 4 |
| Apr 2, 2025 | Politi Jason Chief Technical Ops. Off. | Sale | 3,235 | $13K | Form 4 |
| Apr 1, 2025 | Dorval Allison CFO | Option | 11,250 | — | Form 4 |
| Apr 2, 2025 | Dorval Allison CFO | Sale | 3,350 | $14K | Form 4 |
| Apr 1, 2025 | Lister Troy Chief Scientific Officer | Option | 7,340 | — | Form 4 |
| Apr 2, 2025 | Lister Troy Chief Scientific Officer | Sale | 2,189 | $9K | Form 4 |
| Dec 4, 2024 | Kathiresan Sekar CEO · Director | Gift | 30,000 | — | Form 4 |
| Dec 4, 2024 | Kathiresan Sekar CEO · Director | Gift | 30,000 | — | Form 4 |
GV 2017 GP, L.L.C.
10 percent owner
Date
Jul 25
Shares
1,800,000
Price
$10.50
Value
$18.90M ⚡
Yeshwant Krishna
Director
Date
Jul 25
Shares
1,800,000
Price
$10.50
Value
$18.90M ⚡
Nickerson Joan
Chief Administrative Officer
Date
Jul 25
Shares
17,420
Price
$10.50
Value
$183K
Kathiresan Sekar
CEO · Director
Date
Jul 25
Shares
240,997
Price
$10.50
Value
$2.53M ⚡
Lister Troy
Chief Scientific Officer
Date
Jul 25
Shares
6,952
Price
$10.50
Value
$73K
Politi Jason
Chief Technical Ops. Off.
Date
Jul 25
Shares
16,405
Price
$10.50
Value
$172K
Nickerson Joan
Chief Administrative Officer
Date
Apr 1
Shares
9,315
Price
—
Value
—
Nickerson Joan
Chief Administrative Officer
Date
Apr 2
Shares
2,777
Price
$4.15
Value
$12K
Politi Jason
Chief Technical Ops. Off.
Date
Apr 2
Shares
3,235
Price
$4.15
Value
$13K
▸ Source: SEC EDGAR · Form 4 filings · ⚡ = value ≥ $1M · Award/Option price shows —
About VERV insider trading
VERV insider trades
Verve Therapeutics, Inc. (VERV) insider trading data is sourced from SEC Form 4 filings submitted by corporate insiders, including GV 2017 GP, L.L.C. (10 percent owner), Yeshwant Krishna (Director), Dorval Allison (CFO). Over the past 12 months, 5 insiders have filed transactions with the SEC. VERV insiders have been primarily selling, which may reflect pre-scheduled Rule 10b5-1 plan executions.
For Verve Therapeutics, Inc.'s institutional ownership breakdown and insider ownership percentage, see the Ownership tab → Ownership tab →
Frequently asked questions
VERV insider trading · 5 questionsThe insiders of Verve Therapeutics, Inc. (VERV) include executives and directors such as GV 2017 GP, L.L.C. (10 percent owner), Yeshwant Krishna (Director), Dorval Allison (CFO), among others. Over the past 12 months, 5 insiders have filed Form 4 transactions with the SEC. Insider transactions are required to be reported within 2 business days of the trade date.
▸ Source: FMP /stable/insider-trading/search · SEC EDGAR Form 3 & 4 · acquisitionOrDisposition A=Buy, D=Sell · RSU vesting (M-Exempt) excluded from sentiment bar · As of Jun 9, 2026